CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income			$ 11,206,767	$ 6,324,829
Adjustments to reconcile net income to net cash used in operating activities:
Financing costs - derivative warrant liabilities				776,880
Change in fair value of derivative warrant liabilities		$ (4,364,000)	(10,037,200)	(8,946,200)
Change in fair value of promissory note - related party	$ (517,997)		(525,060)
Interest income from investments held in Trust Account	(1,248,064)	(4,241)	(1,662,611)	(12,110)
Changes in operating assets and liabilities:
Accounts payable			(153,165)	229,233
Accrued expenses			92,960	(8,276)
Prepaid expenses			338,238	(602,993)
Net cash used in operating activities			(740,071)	(2,238,637)
Cash Flows from Investing Activities:
Principal deposited in Trust Account				(276,000,000)
Cash used in investing activities				(276,000,000)
Cash Flows from Financing Activities:
Repayment of note payable to related parties				(280,000)
Proceeds from working capital loan			775,372
Proceeds received from initial public offering, gross				276,000,000
Proceeds received from private placement				8,020,000
Offering costs paid			(70,000)	(5,426,316)
Net cash provided by financing activities			705,372	278,313,684
Net change in cash			(34,699)	75,047
Cash - beginning of the period			132,241	111,696
Cash - end of the period	$ 97,542	$ 186,743	$ 97,542	186,743
Supplemental disclosure of noncash investing and financing activities:
Offering costs in accrued expenses				70,000
Deferred underwriting commissions in connection with the initial public offering				$ 9,660,000